Paid Clinical Trials and Focus Groups by Location |
|
|
|
Conditions: Leukemia; Mucositis; Oral Complications
Interventions: Biological: epratuzumab; Biological: palifermin; Biological: rituximab; Drug: cyclophosphamide; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: etoposide; Drug: fludarabine phosphate; Drug: imatinib mesylate; Drug: melphalan; Drug: mercaptopurine; Drug: methotrexate; Drug: nelarabine; Drug: pegaspargase; Drug: vincristine sulfate; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: assessment of therapy complications; Radiation: total-body irradiation
Sponsor: University College London Hospitals
Recruiting - verified March 2010
Condition: Leg Ulcer
Interventions: Device: AQUACEL® Ag; Device: Urgotul® Silver
Sponsor: ConvaTec Inc.
Recruiting - verified March 2010
Condition: Stress
Intervention:
Sponsor: SPD Development Company Limited
Recruiting - verified March 2010
Conditions: Type 2 Diabetes; Hypogonadism
Intervention: Drug: Testosterone
Sponsor: Tameside Hospital NHS Foundation Trust
Not yet recruiting - verified November 2008
Condition: Surgical Wound Dehiscence
Interventions: Device: Strattice(TM) Reconstructive Tissue Matrix; Procedure: Suture/suture with absorbable mesh
Sponsor: LifeCell
Not yet recruiting - verified March 2010
Condition: Myocardial Infarction
Intervention:
Sponsors: University of Dundee; NHS Tayside
Active, not recruiting - verified March 2010
Condition: Pulmonary Arterial Hypertension (Idiopathic, Familial or Anorexigen-associated)
Interventions: Drug: Dichloroacetate Sodium; Drug: Dichloroacetate Sodium; Drug: Dichloroacetate Sodium
Sponsors: University of Alberta; Imperial College London
Enrolling by invitation - verified March 2010
Conditions: Advanced Gastric Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: AUY922; Drug: Docetaxel or Irinotecan
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified March 2010
Condition: Postoperative Pain
Interventions: Drug: Morphine 6-glucuronide; Drug: Morphine
Sponsors: Paion UK Ltd.; Chiltern International Ltd.; HFL Ltd.
Completed - verified March 2010
Condition: Pilonidal Sinus
Intervention:
Sponsor: ConvaTec Inc.
Completed - verified March 2010
Conditions: Fallopian Tube Cancer; Ovarian Cancer
Interventions: Biological: bevacizumab; Drug: capecitabine; Drug: carboplatin; Drug: oxaliplatin; Drug: paclitaxel; Procedure: quality-of-life assessment
Sponsor: University College London Hospitals
Recruiting - verified March 2010
Condition: Cardiac Dysrhythmia
Intervention:
Sponsors: University of Dundee; NHS Tayside
Active, not recruiting - verified March 2010
Conditions: Accidental Falls; Exercise
Intervention:
Sponsors: NHS Grampian; British Geriatric Society
Completed - verified June 2009
Condition: Atrail Fibrillation
Intervention:
Sponsors: University of Dundee; NHS Tayside
Active, not recruiting - verified March 2010
Condition: Breast Cancer Mortality
Intervention: Other: Invitation for breast screening
Sponsors: University of Oxford; Department of Health, United Kingdom
Not yet recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin glargine; Drug: NN1250; Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Hypertension
Interventions: Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491)
Sponsor: Takeda Global Research & Development Center, Inc.
Not yet recruiting - verified February 2010
Condition: Cytomegalovirus Infection
Interventions: Biological: Adoptive Cellular Therapy; Drug: Best available antiviral drug therapy
Sponsors: Cell Medica Ltd; Wellcome Trust; Choice Pharma Ltd; Commitum AB; BioAnaLab
Recruiting - verified February 2010
Condition: Ovarian Cancer
Interventions: Drug: olaparib; Drug: paclitaxel; Drug: carboplatin
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Hormone Withdrawal Associated Symptoms
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300); Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Conditions: Malnutrition; Aged
Interventions: Dietary Supplement: Standard ONS (Fortisip, Fortisp Extra or Fortisip Multifibre); Dietary Supplement: High Energy, low volume ONS (Cooper, Cooper Fibre, Cooper Protein)
Sponsor: Nutricia UK Ltd
Recruiting - verified March 2010
Condition: Prostatic Neoplasms
Intervention:
Sponsor: Sanofi-Aventis
Recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: Matching placebo; Drug: Otelixizumab
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Colorectal Cancer
Intervention:
Sponsors: Newcastle University; Northumbria Healthcare NHS Foundation Trust
Recruiting - verified February 2010
Conditions: Attention; Memory; Mood; Mental Fatigue
Intervention:
Sponsor: Northumbria University
Completed - verified February 2010
Conditions: Cerebral Blood Flow; Cognitive Function
Interventions: Dietary Supplement: DHA-rich fish oil; Dietary Supplement: Placebo
Sponsors: Northumbria University; Ginsana SA
Completed - verified February 2010
Conditions: Cognitive Function; Mood
Interventions: Dietary Supplement: n-3 PUFAs; Dietary Supplement: Placebo; Dietary Supplement: n-3 PUFAs
Sponsors: Northumbria University; Ginsana SA
Completed - verified February 2010
Condition: Severe Aortic Valve Stenosis
Intervention: Device: Medtronic CoreValve System
Sponsor: Medtronic Bakken Research Center
Not yet recruiting - verified March 2010
Condition: Severe Respiratory Syncytial Virus Infection
Intervention:
Sponsor: Abbott
Completed - verified February 2010
Condition: Asthma
Interventions: Drug: propranolol; Drug: placebo
Sponsors: University of Dundee; Chief Scientist Office of the Scottish Government
Not yet recruiting - verified February 2010
Condition: Bacterial Infections
Intervention: Biological: Gut infection challenge with M bovis
Sponsors: St George's, University of London; University of British Columbia; Wellcome Trust; Fundação Ataulpho de Paiva, Rio de Janeiro, Brasil; Foundation for the National Institutes of Health; Bill and Melinda Gates Foundation
Completed - verified February 2010
Condition: Ischaemia-reperfusion (IR) Injury
Interventions: Drug: C-type natriuretic peptide (CNP); Drug: Saline; Drug: Acetylcholine
Sponsors: Queen Mary University of London; University College, London
Not yet recruiting - verified February 2010
Condition: Type 1 Diabetes
Interventions: Other: Closed-loop insulin delivery; Other: Standard insulin pump treatment
Sponsors: University of Cambridge; Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting - verified February 2010
Conditions: HIV; HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
Sponsor: St Stephens Aids Trust
Not yet recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: AZD5069
Sponsors: AstraZeneca; Quintiles
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin detemir (Levemir®); Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Neuromuscular Disease
Interventions: Drug: A0001 (alpha-tocopherolquinone); Drug: Placebo
Sponsor: Penwest Pharmaceuticals Co.
Recruiting - verified February 2010
Condition: HCV Infection
Interventions: Drug: GS-9256; Drug: GS-9190; Drug: Ribavirin
Sponsor: Gilead Sciences
Recruiting - verified March 2010
Conditions: Osteoarthritis; Pain
Interventions: Drug: MEDI-578; Drug: Placebo for MEDI-578
Sponsors: AstraZeneca; MedImmune LLC
Recruiting - verified February 2010
Condition: Dietary Intervention
Interventions: Dietary Supplement: probiotic; Dietary Supplement: prebiotic; Dietary Supplement: Synbiotic; Dietary Supplement: Placebo
Sponsor: University of Reading
Not yet recruiting - verified February 2010
Condition: Liver Cirrhosis
Intervention:
Sponsors: University College London Hospitals; Medical Research Council
Recruiting - verified April 2008
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
Not yet recruiting - verified February 2010
Condition: HIV Infections
Interventions: Biological: HIV-v (Low Dose); Biological: HIV-v (High Dose); Biological: HIV-v (Control)
Sponsor: PepTcell Limited
Recruiting - verified February 2010
Condition: Coronary Artery Disease
Intervention: Device: Radi pressure wire (pressure wire assessment)
Sponsor: Southampton University Hospitals NHS Trust
Recruiting - verified October 2009
Condition: Paroxysmal Atrial Fibrillation
Interventions: Drug: Dronedarone; Drug: Placebo
Sponsor: Eastbourne General Hospital
Not yet recruiting - verified February 2010
Conditions: Breast Cancer; Bone Metastases
Intervention: Drug: Radium-223 chloride (Alpharadin)
Sponsor: Algeta ASA
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: CHF 5188 pMDI; Drug: Budesonide extrafine pMDI; Drug: Seretide(r) Evohaler(r)
Sponsor: Chiesi Farmaceutici S.p.A.
Recruiting - verified February 2010
Conditions: Respiratory Tract Infections; Influenza
Interventions: Dietary Supplement: Cholecalciferol (Vitamin D/Vigantol oil); Dietary Supplement: Miglyol oil
Sponsors: Barts & The London NHS Trust; National Health Service, United Kingdom
Not yet recruiting - verified February 2010
Condition: Hepatitis C
Interventions: Biological: Ad6NSmut; AdCh3NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut
Sponsors: Okairos; University of Oxford
Recruiting - verified February 2010
Condition: Asthma
Intervention: Drug: Hydrocortisone/ Placebo and Propranolol
Sponsors: University of Dundee; NHS Tayside
Not yet recruiting - verified December 2009
Condition: Healthy
Interventions: Drug: granisetron IV; Drug: granisetron patch
Sponsor: Prostrakan Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Intra-abdominal Infection
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039); Drug: Ertapenem, Amoxicillin/clavulanate
Sponsor: Bayer
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN1250; Drug: insulin glargine
Sponsor: Novo Nordisk
Recruiting - verified February 2010
Condition: Colorectal Cancer
Interventions: Drug: Eicosapentaenoic acid free fatty acid; Drug: Placebo
Sponsor: University of Leeds
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN1250; Drug: insulin glargine
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: AZD6553; Drug: Placebo
Sponsors: AstraZeneca; Quintiles
Not yet recruiting - verified February 2010
Condition: Alzheimer's Disease
Interventions: Biological: Etanercept; Other: Placebo
Sponsors: University of Southampton; Hampshire Partnership NHS Foundation Trust; Wyeth
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Etoricoxib; Drug: Diclofenac
Sponsor: Northumbria Healthcare NHS Foundation Trust
Not yet recruiting - verified January 2010
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
